H.R. 2880 · 118th Congress
Protecting Patients Against PBM Abuses Act
Introduced on Apr 26, 2023 by Earl L. "Buddy" Carter (R-GA-1). 45 cosponsors, 19 of them from another party. Latest action (Dec 17, 2024): Referred to the Subcommittee on Health.
- Stage
- Introduced
- Introduced
- Apr 26, 2023
- Cosponsors
- 45
- 19 from the other party
- Policy area
- Health
Progress
The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.
- Introduced
- 2Reported by committee
- 3Passed one chamber
- 4Passed both chambers
- 5Sent to the President
- 6Became law
Official title
To amend title XVIII of the Social Security Act to establish certain requirements for pharmacy benefit managers under part D of the Medicare program.
Subjects
- Government information and archives
- Health care costs and insurance
- Medicare
- Prescription drugs
Summary
The Congressional Research Service has not summarized this measure yet.
Sponsor and cosponsors
Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.
Democrats · 19
- Jake AuchinclossD-MA-4original
- Lisa Blunt RochesterD-DEoriginal
- Deborah K. RossD-NC-2signed on Aug 25, 2023
- Emanuel CleaverD-MO-5signed on Apr 15, 2024
- Mikie SherrillD-NJ-11signed on Apr 23, 2024
- Nanette Diaz BarragánD-CA-44signed on May 7, 2024
- Sheila Cherfilus-McCormickD-FL-20signed on May 7, 2024
- Donald G. DavisD-NC-1signed on May 16, 2024
- Matt CartwrightD-PA-8signed on May 22, 2024
- Jonathan L. JacksonD-IL-1signed on May 22, 2024
- Gabe VasquezD-NM-2signed on Jun 3, 2024
- Abigail Davis SpanbergerD-VA-7signed on Jun 11, 2024
- Andrea SalinasD-OR-6signed on Jun 12, 2024
- Yadira CaraveoD-CO-8signed on Jul 22, 2024
- Mike LevinD-CA-49signed on Jul 23, 2024
- Raja KrishnamoorthiD-IL-8signed on Sep 9, 2024
- Joseph D. MorelleD-NY-25signed on Oct 11, 2024
- Wiley NickelD-NC-13signed on Nov 1, 2024
- Robert MenendezD-NJ-8signed on Nov 18, 2024
Republicans · 26
- Nicole MalliotakisR-NY-11original
- Jefferson Van DrewR-NJ-2signed on Jun 30, 2023
- Mariannette Miller-MeeksR-IA-1signed on Jul 26, 2023
- Neal P. DunnR-FL-2signed on Aug 25, 2023
- Jerry L. CarlR-AL-1signed on Sep 13, 2023
- Tracey MannR-KS-1signed on Sep 22, 2023
- A. Drew Ferguson IVR-GA-3signed on Oct 30, 2023
- Diana HarshbargerR-TN-1signed on Nov 8, 2023
- Rick W. AllenR-GA-12signed on Nov 28, 2023
- Carol D. MillerR-WV-1signed on Jan 10, 2024
- David G. ValadaoR-CA-22signed on Mar 19, 2024
- Austin ScottR-GA-8signed on May 7, 2024
- Charles J. "Chuck" FleischmannR-TN-3signed on May 21, 2024
- Richard HudsonR-NC-9signed on May 21, 2024
- Richard McCormickR-GA-6signed on Jun 18, 2024
- Michael LawlerR-NY-17signed on Jun 25, 2024
- Glenn GrothmanR-WI-6signed on Jun 26, 2024
- John W. RoseR-TN-6signed on Jul 22, 2024
- Mike FloodR-NE-1signed on Jul 23, 2024
- Nick LaLotaR-NY-1signed on Jul 30, 2024
- Jennifer A. KiggansR-VA-2signed on Aug 2, 2024
- John JamesR-MI-10signed on Aug 13, 2024
- Derrick Van OrdenR-WI-3signed on Sep 9, 2024
- Lloyd SmuckerR-PA-11signed on Sep 19, 2024
- Mike GarciaR-CA-27signed on Oct 4, 2024
- Claudia TenneyR-NY-24signed on Oct 11, 2024
Roll calls
Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.
No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.
History
Every action as published, oldest first. Roll calls link to how each member voted.
- Apr 26, 2023Introduced in House
- Apr 26, 2023Introduced in House
- Apr 26, 2023 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Apr 26, 2023 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Apr 28, 2023 · HouseReferred to the Subcommittee on Health.
- Nov 15, 2023 · HouseSubcommittee Consideration and Mark-up Session Held
- Nov 15, 2023 · HouseForwarded by Subcommittee to Full Committee by Voice Vote.
- Dec 5, 2023 · HouseCommittee Consideration and Mark-up Session Held
- Dec 6, 2023 · HouseCommittee Consideration and Mark-up Session Held
- Dec 6, 2023 · HouseOrdered to be Reported (Amended) by the Yeas and Nays: 46 - 0.
- Dec 17, 2024 · HouseReferred to the Subcommittee on Health.
Committees
Committees and subcommittees the measure was referred to.
Agencies in its committees' jurisdiction
Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.
Who lobbied on it
Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.
- PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA17 reports$37.4M reported (all issues)
- Pharmaceutical Industry Labor-Management Association12 reports$440K reported (all issues)
- SANOFI US SERVICES INC11 reports$16.2M reported (all issues)
- AMGEN INC.9 reports
- EMD SERONO, INC.9 reports$3.2M reported (all issues)
- HealthCare Institute of New Jersey9 reports$442.6K reported (all issues)
- Pharmaceutical Research and Manufacturers of America (PhRMA)8 reports$280K reported (all issues)
- AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP)5 reports$14.2M reported (all issues)
- AMERICAN COLLEGE OF PHYSICIAN SERVICES, INC5 reports$1.6M reported (all issues)
- AMERICAN COLLEGE OF PHYSICIANS5 reports$564.3K reported (all issues)
- ASSOCIATION FOR ACCESSIBLE MEDICINES5 reports$3M reported (all issues)
- CVS HEALTH5 reports$11M reported (all issues)
- ELEVANCE HEALTH, INC.5 reports$7.6M reported (all issues)
- Epilepsy Foundation5 reports$330K reported (all issues)
- GSK (fka GLAXOSMITHKLINE INC.)5 reports$6.3M reported (all issues)
- HIGHMARK INC.5 reports$830K reported (all issues)
- INDEPENDENT PHARMACY COOPERATIVE5 reports
- KAISER FOUNDATION HEALTH PLAN INC.5 reports$2.9M reported (all issues)Federal contractor: KAISER FOUNDATION HEALTH PLAN OF WASHINGTONAI match · 97%
- MERCK & CO., INC.5 reports$11.1M reported (all issues)Federal contractor: MERCK SHARP & DOHME LLC$445.3K in contracts, FY2026AI match · 100%
- NATIONAL ASSOCIATION OF CHAIN DRUG STORES, INC.5 reports$4.2M reported (all issues)
- NATIONAL COMMUNITY PHARMACISTS ASSOCIATION5 reports$1.8M reported (all issues)Federal contractor: NATIONAL COMMUNITY PHARMACISTS ASSOCIATIONAI match · 100%
- NOVARTIS CORPORATION5 reports$6.9M reported (all issues)Federal contractor: NOVARTIS PHARMACEUTICALS CORPORATION$36.2M in contracts, FY2026AI match · 100%
- National Taxpayers Union5 reports$150K reported (all issues)
- The Cigna Group and subsidiaries (Formerly Cigna Corporation5 reports$10.2M reported (all issues)
- GENENTECH INC.4 reports
- PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION4 reports$17.8M reported (all issues)
- TAKEDA PHARMACEUTICALS AMERICA, INC.4 reports$3M reported (all issues)Federal contractor: TAKEDA PHARMACEUTICALS AMERICA, INC.$1.6M in contracts, FY2026AI match · 100%
- The Leukemia & Lymphoma Society4 reports$1M reported (all issues)
- Blue Cross and Blue Shield Association3 reports$5.2M reported (all issues)
- Blue Cross and Blue Shield of Florida, Inc.3 reports$600K reported (all issues)
- CAMBIA HEALTH SOLUTIONS INC.3 reports$2M reported (all issues)
- GILEAD SCIENCES, INC.3 reportsFederal contractor: GILEAD SCIENCES INCAI match · 100%
- GUIDEWELL MUTUAL HOLDING CORPORATION3 reports$30K reported (all issues)
- Health Care Service Corporation, a Mutual Legal Reserve Company (HCSC)3 reports$3.4M reported (all issues)Federal contractor: HEALTH CARE SERVICE CORPORATION, A MUTUAL LEGAL RESERVE COMPANY$16M in contracts, FY2026AI match · 100%
- AMNEAL PHARMACEUTICALS INC.2 reports$440K reported (all issues)Federal contractor: AMNEAL PHARMACEUTICALS OF NEW YORK, LLC$467.7K in contracts, FY2026AI match · 98%
- Astellas Pharma US, Inc.2 reportsFederal contractor: ASTELLAS PHARMA US, INC.AI match · 100%
- BLUE CROSS AND BLUE SHIELD OF KANSAS, INC.2 reports$10K reported (all issues)
- BLUE CROSS BLUE SHIELD OF MICHIGAN2 reports$538.2K reported (all issues)
- BRISTOL-MYERS SQUIBB COMPANY2 reports$2.7M reported (all issues)Federal contractor: BRISTOL-MYERS SQUIBB COMPANY$8.8M in contracts, FY2026AI match · 100%
- Cigna Corporation2 reports$180K reported (all issues)Federal contractor: CIGNA WORLDWIDE INSURANCE BRANCH$2.5M in contracts, FY2026AI match · 99%
Reports filed in 2023, 2024, 2025, 2026.
Sources and method
Every figure on this page traces to these records.
- Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
- Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
- House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
- Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
- Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
- Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
- Money and votes are shown side by side; neither explains the other.